Research on Optimization and Evaluation of Oral Cancer Screening Methods
Oral Cancer
About this trial
This is an interventional screening trial for Oral Cancer focused on measuring Oral cancer, Screening Method
Eligibility Criteria
Inclusion Criteria:
- aged 40-69 years old.
Exclusion Criteria:
- No.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Other
Experimental
clinical observation combined with pathological biopsy
Clinical observation, in vivo staining combined with pathological biopsy
Clinical observation (including inspection and palpation) combined with pathological biopsy. That is, inspecting and palpating the oral cavity and neck of the screened object. If positive lesions are found, then further pathological biopsy will be performed.
Clinical observation (including inspection and palpation), in vivo staining (reagent: toluidine blue) combined with pathological biopsy. That is, inspecting and palpating the oral cavity and neck of the screened object. At the same time, in vivo staining is performed on each participant. The reagent used for staining is toluidine blue. As long as the screening subjects found positive lesions or abnormal living body staining, pathological biopsy was performed.